✦ LIBER ✦

A controlled trial of acyclovir in stable chronic HBsAg, HBeAg-positive carriers

✍ Scribed by Alexander, G.J.M.; Fagan, E.A.; Hegarty, J.E.; Rolando, N.; Guarner, P.; Eddleston, A.L.W.F.; Williams, Roger

Book ID: 123356409
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 304 KB
Volume: 3
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(86)80110-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled trial of acyclovir in chronic

Controlled trial of acyclovir in chronic HBsAg, HBeAg positive carriers

📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 49 KB

High frequency of HBeAg-minus chronic HB

High frequency of HBeAg-minus chronic HBsAg-positive liver disease in Egypt

✍ A. El-Zayadi; M. Sober; D. Lavanchy; N. Hasseeb; O. Selim; C. Mayerat; H. Dabbou 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Efficacy of consensus interferon in trea

Efficacy of consensus interferon in treatment of HbeAg-positive chronic hepatitis B: a multicentre, randomized controlled trial

✍ YongLi Zheng; LianSan Zhao; TaiXiang Wu; ShuHua Guo; YaGang Chen; TaoYou Zhou 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 192 KB

Controlled clinical trial of acyclovir i

Controlled clinical trial of acyclovir in chronic hepatitis B virus infection

✍ Dr. Graeme J. M. Alexander; Elizabeth A. Fagan; John E. Hegarty; Adrian L. W. F. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

A randomised, controlled trial comparing acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days, with no other therapy, was carried out in 30 stable HBsAg carriers seropositive for HBeAg for more than 6 months. Twenty-eight had hepatitis B virus DNA-polymerase activity and/or hepatitis B vi

The higher aspartate aminotransferase bu

The higher aspartate aminotransferase but the lower HBV DNA in sera, the more severe histopathology of chronic hepatitis in the young HBeAg positive chronic HBsAg carriers

✍ Lee, Soong Hwan; Lee, Dong Hoo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A randomized controlled trial of lymphob

A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg

✍ Giovanna Fattovich; Patrizia Farci; Massimo Rugge; Lucio Brollo; Antonella Manda 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Ongoing hepatitis B virus replication in the presence of antibody to HBeAg can be observed in patients with active liver disease. These forms of chronic hepatitis B have been described as having a poor prognosis. We have conducted a randomized controlled trial to assess the efficacy of lymphoblastoi